JPMorgan analyst Jeffrey Zekauskas downgraded Cabot (CBT) to Underweight from Neutral with an unchanged price target of $105. The firm expects prices for carbon black in the U.S. to flatten out after a multi-year period of increase. Cabot is trading at a 3-3.5 times multiple point premium to Orion, the analyst tells investors in a research note. JPMorgan cites relative valuation for the downgrade of Cabot.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBT:
